Key Clinical Research Strategies, Innovations Featured at CenterWatch's Forum on Optimizing Clinical Research Performance

        Print
| Source: iiBIG

PORT WASHINGTON, N.Y., July 9, 2014 (GLOBE NEWSWIRE) -- CenterWatch and iiBIG will present the 2nd Annual Forum on Optimizing Clinical Research Performance on September 15-16th in Boston, Mass., for senior-level clinical research professionals from pharma, CROs, research centers and niche service providers. The conference will feature over 30 thought-leaders and a unique agenda with data-driven analysis, cutting edge trends, and forward-thinking solutions to drive change across the global clinical research landscape.

Key conference topics will focus on the past performance and future trends of drug development; progressive solutions driving clinical research performance improvement; the role of private equity in CRO/site consolidation; how eClinical technologies are transforming drug development; engaging patients via data sharing; patient recruitment strategies; the future of the community-based site; credentialing principal investigators (PIs); utilizing metrics in CRO/site relationships; executing a successful adaptive trial design; clinical research globalization; and bringing clinical research into the next decade.

The day-and-a-half conference will conclude with a closing plenary from Mark Weiner, M.D., a board-certified neurologist who self-diagnosed his brain cancer and will chronicle his journey in the presentation "When Doctor Becomes Patient."

The speaking faculty will include leading players in the clinical research space from: ACRP; Amgen; Aptiv Solutions, an ICON company; Aspire IRB; BBK Worldwide; CDISC; CenterWatch; CFS Clinical; CISCRP; ClinEdge; Clinical Research of South Florida; CORE/Benchmark Research; DePuy Synthes, a J&J Medical Device company; TrialNetworks, a DrugDev company; Edgemont Capital Partners; Endo Pharmaceuticals; Fairmount Partners; First Analysis; INC Research; Langland; MedPoint Digital; Oracle Health Sciences; Parexel; PHT Corporation; PMG Research; Purdue Pharma L.P.; Quintiles; Quorum Review IRB; Roche/Genentech; Shire; SunTrust Robinson Humphrey; The Avoca Group; Tufts CSDD; Tufts University School of Medicine; Veeva Systems; and The WIRB-Copernicus Group.

Conference sponsors and exhibitors include: Aspire IRB, Benchmark Research, ClinEdge, CFS Clinical, DrugDev, HealthCarePoint, MedPoint Digital, Quorum IRB, and PMG Research.

To view the complete agenda and speaking faculty, please visit: http://www.iibig.com/CWAnnual.

The 2nd Annual Forum on Optimizing Clinical Research Performance is presented in partnership between CenterWatch, the global leader in providing timely and content-rich clinical research information and iiBIG, a leading presenter of professional B2B conferences for decision-makers in the healthcare, technology, and financial services sectors.

About CenterWatch

Since 1994, CenterWatch has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from top sponsors and CROs to research sites and niche providers, as well as an engaged population of patients interested in clinical research and volunteering. For more information, please visit: http://www.centerwatch.com.

About iiBIG

iiBIG (International Institute for Business Information & Growth) is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. For more information, please visit: http://www.iibig.com.

Don Buford
Chief Executive Officer
iiBIG (International Institute for Business Information
& Growth)
Phone: 212-300-2521
E-mail: 
http://www.iibig.com/CWAnnual